open access

Vol 13, No 3 (2009)
Prace oryginalne
Published online: 2009-05-11
Get Citation

Effects of xanthine oxidase inhibition with allopurinol on arterial blood pressure depending on antihypertensive therapy

Katarzyna Kostka-Jeziorny, Paweł Uruski, Andrzej Tykarski
Nadciśnienie tętnicze 2009;13(3):175-191.

open access

Vol 13, No 3 (2009)
Prace oryginalne
Published online: 2009-05-11

Abstract


Background Arterial hypertension is commonly associated with hyperuricemia. Numerous clinical studies have shown that xanthine oxidase inhibition reduces arterial blood pressure in animal models. Furthermore, allopurinol appears to reduce blood pressure in adolescents with newly diagnosed hypertension. The results of studies represent a potentially new therapeutic approach, that of control of biochemical cause of hypertension, rather than nonspecifically lowering blood pressure. Allopurinol appears to have effect an endothelial function in hypertensives in contrast to uricosuric agents. The aim of our study was to determine the effects of allopurinol on arterial blood pressure depending on hypouremic action of angiotensin converting enzyme inhibitor (ACE-I) or thiazide therapy.
Material and Methods The research was carried out in years 2006-2008 in the Department of Hypertension, Angiology and Internal Diseases, University of Medical Sciences in Poznan. 66 patients with primary, mild-to-moderate arterial hypertension diagnosis based on traditional measurements were qualified for research. The patients with suspected or diagnosed secondary hypertension, white-coat hypertension, unstable coronary heart disease, myocardial infarction in history, diabetes and other coexisting chronic illness were excluded. Patients aged 25 to 70 (mean age 46.17 ± 10.89) have been studied. Antihypertensive therapy was based on perindopril (n = 35) and hydrochlorothiazide (n = 31). After 8 weeks of antihypertensive therapy, allopurinol 150 mg daily was added for 2 months. Vitits were conducted in the morning. Following 1-h of rest, blood samples were collected for measurement of urate, urea, creatinine, glucose, renin acivity, liver function tests, electrolytes, plasma lipids, morphology. Ambulatory blood pressure monitoring (ABPM) was made. Twentyfour- hour urate excretion was evaluated. Measurements were taken at baseline, after 8 weeks of antihypertensive therapy and after next 8-week of antihypertensive therapy plus allopurinol.
Results In the whole studied group SBP at visit V4 was 134,45 ± 7,37 mm Hg, DBP 83,72 ± 5,87 mm Hg, PP 50,78 ± 7,31 mm Hg. In V5, the mean SBP, DBP and PP were: 134,89 ± 7,93 mm Hg, 84,35 ± 7,29 mm Hg and 50,54 ± 7,53 mm Hg (no significant changes). In P+H group, at V4 the mean SBP24h was 128,87 ± 9,1 mm Hg, DBP24h 78,20 ± 6,82 mm Hg and PP24h 50,67 ± 6,99 mm Hg. After allopurinol treatment in whole group, no significant changes in office SBP, DBP and ambulatory SBP, DBP were observed. Also, no significant changes in office BP and ambulatory BP were observed after treatment with allopurinol in group P and H.
Conclusions
1. There were no significant changes in blood pressure after allopurinol treatment regardless of uric acid level reduction.
2. Arterial blood pressure after the antihypertensive therapy was correlated with the effectiveness of allopurinol. The lower was arterial blood pressure, the less effective was allopurinol.

Abstract


Background Arterial hypertension is commonly associated with hyperuricemia. Numerous clinical studies have shown that xanthine oxidase inhibition reduces arterial blood pressure in animal models. Furthermore, allopurinol appears to reduce blood pressure in adolescents with newly diagnosed hypertension. The results of studies represent a potentially new therapeutic approach, that of control of biochemical cause of hypertension, rather than nonspecifically lowering blood pressure. Allopurinol appears to have effect an endothelial function in hypertensives in contrast to uricosuric agents. The aim of our study was to determine the effects of allopurinol on arterial blood pressure depending on hypouremic action of angiotensin converting enzyme inhibitor (ACE-I) or thiazide therapy.
Material and Methods The research was carried out in years 2006-2008 in the Department of Hypertension, Angiology and Internal Diseases, University of Medical Sciences in Poznan. 66 patients with primary, mild-to-moderate arterial hypertension diagnosis based on traditional measurements were qualified for research. The patients with suspected or diagnosed secondary hypertension, white-coat hypertension, unstable coronary heart disease, myocardial infarction in history, diabetes and other coexisting chronic illness were excluded. Patients aged 25 to 70 (mean age 46.17 ± 10.89) have been studied. Antihypertensive therapy was based on perindopril (n = 35) and hydrochlorothiazide (n = 31). After 8 weeks of antihypertensive therapy, allopurinol 150 mg daily was added for 2 months. Vitits were conducted in the morning. Following 1-h of rest, blood samples were collected for measurement of urate, urea, creatinine, glucose, renin acivity, liver function tests, electrolytes, plasma lipids, morphology. Ambulatory blood pressure monitoring (ABPM) was made. Twentyfour- hour urate excretion was evaluated. Measurements were taken at baseline, after 8 weeks of antihypertensive therapy and after next 8-week of antihypertensive therapy plus allopurinol.
Results In the whole studied group SBP at visit V4 was 134,45 ± 7,37 mm Hg, DBP 83,72 ± 5,87 mm Hg, PP 50,78 ± 7,31 mm Hg. In V5, the mean SBP, DBP and PP were: 134,89 ± 7,93 mm Hg, 84,35 ± 7,29 mm Hg and 50,54 ± 7,53 mm Hg (no significant changes). In P+H group, at V4 the mean SBP24h was 128,87 ± 9,1 mm Hg, DBP24h 78,20 ± 6,82 mm Hg and PP24h 50,67 ± 6,99 mm Hg. After allopurinol treatment in whole group, no significant changes in office SBP, DBP and ambulatory SBP, DBP were observed. Also, no significant changes in office BP and ambulatory BP were observed after treatment with allopurinol in group P and H.
Conclusions
1. There were no significant changes in blood pressure after allopurinol treatment regardless of uric acid level reduction.
2. Arterial blood pressure after the antihypertensive therapy was correlated with the effectiveness of allopurinol. The lower was arterial blood pressure, the less effective was allopurinol.
Get Citation

Keywords

arterial hypertension; hyperuricemia; allopurinol

About this article
Title

Effects of xanthine oxidase inhibition with allopurinol on arterial blood pressure depending on antihypertensive therapy

Journal

Arterial Hypertension

Issue

Vol 13, No 3 (2009)

Pages

175-191

Published online

2009-05-11

Bibliographic record

Nadciśnienie tętnicze 2009;13(3):175-191.

Keywords

arterial hypertension
hyperuricemia
allopurinol

Authors

Katarzyna Kostka-Jeziorny
Paweł Uruski
Andrzej Tykarski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl